Drugs from Eli Lilly and Boehringer Ingelheim grabbed the spotlight at the EASL congress on liver diseases, both showing promising results in metabolic dysfunction-associated steatohepatitis (MASH).
Novo Nordisk's GLP-1 receptor agonist semaglutide has shown efficacy as a treatment for metabolic dysfunction-associated steatohepatitis (MASH) in a phase 3 trial, potentially teeing up US and ...
Bobby "Boris" Pickett was one-half of the minds behind "Monster Mash," but that's barely half his life story Every Halloween, Robert George Pickett rises from the grave. (Figuratively.) The song that ...
Many MASH cirrhosis trials use histologic endpoints, but a new review finds limited standardization of these outcomes across studies. Clinical trials of therapies for metabolic dysfunction-associated ...
The key to light, fluffy celeriac mash is to include some floury potatoes (such as Maris Piper or King Edward), this ensures you'll get smooth creamy mash, just as it ought to be. Put the potatoes and ...
You wake in the night, your chest burning. Sometimes the pain is so intense you think it's a heart attack. For the 60 million Americans who get heartburnat least once a month, the pain isn't just a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results